Trial@home, CHDR’s dedicated strategy for off-site clinical trials, enables investigators to collect information as trial participants go about their day to day activities.

Early Phase Experts

As a full-service contract research organization, Southern Star Research has the knowledge, industry relationships and technical expertise to get your early-phase clinical trial up and running safely and efficiently.

With a broad range of experience delivering Phase 1 Healthy Volunteer, First in Human, First in Patient and Phase 2 trials, we know just how important it is for your asset to succeed in the early development lifecycle. Our experienced team will help you obtain high-quality data that will appeal to future investors, meet the requirements of international regulatory bodies such as the FDA, EMA, PMDA, and Health Canada, and prepare your product for larger Phase 3 and 4 studies, partnerships, licensing, and sale.

Whatever your clinical trial needs, we can provide a flexible, bespoke solution that will not only meet your regulatory requirements but also position your product for commercial success.

The ISPOR Education Center provides instant access to Health Economics and Outcomes Research (HEOR) education with on-demand programs delivered through a personalized, powerful, and flexible learning platform. Working at their own time and pace, individuals can drive their professional development by growing their knowledge and skills with topical, relevant, and innovative course curricula.

iMedNet is MedNet Solutions’ latest eClinical technology platform. It provides non-technical clinical research personnel with a fast, intuitive and cost-effective solution for building and managing their own clinical studies.

A centralized command center for patient randomization and drug supply management—built for today’s complex clinical trials.

More than just an electronic data collection tool, our robust clinical data management system combines an intuitive user interface, seamless online and offline data capture capabilities, and comprehensive data management for clinical trials in a single solution.

With ParexelAI™, you're not just optimizing your current development timeline, you're unlocking the ability to run more programs simultaneously across our global network and compress critical timelines. In a landscape where speed to market directly impacts patient outcomes, ParexelAI empowers you to innovate and make a meaningful difference in patients' lives.

Zelta’s EDC has been used in more than 4,000 studies from startup to submission, across all phases, including over 500 phase 3c trials and 23 therapeutic areas.